Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy approaches for hematological cancers. | iScience | 2022 | 36325064 | PubTator, text mining | PubMed |
| The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions. | Front Pharmacol | 2022 | 36313336 | PubTator, text mining | PubMed |
| Advances in immunotherapy for glioblastoma multiforme. | Front Immunol | 2022 | 36311781 | PubTator, text mining | PubMed |
| Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape. | Front Immunol | 2022 | 36311702 | PubTator, text mining | PubMed |
| Two novel lncRNAs AF111167.2 and AL162377.1 targeting miR-21-5p mediated down expression of SYDE2 correlates with poor prognosis and tumor immune infiltration of ccRCC. | Heliyon | 2022 | 36311369 | PubTator, text mining | PubMed |
| Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy. | Cancer Cell | 2022 | 36306792 | PubTator, text mining | PubMed |
| Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. | Clin Transl Med | 2022 | 36305631 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies. | Dis Markers | 2022 | 36304254 | PubTator, text mining | PubMed |
| Clinical and Translational Advances in Glioma Immunotherapy. | Neurotherapeutics | 2022 | 36303101 | PubTator, text mining | PubMed |
| Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer. | Front Oncol | 2022 | 36300088 | PubTator, text mining | PubMed |
| Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy. | Pathogens | 2022 | 36297203 | PubTator, text mining | PubMed |
| Vitamin D as a Nutri-Epigenetic Factor in Autoimmunity-A Review of Current Research and Reports on Vitamin D Deficiency in Autoimmune Diseases. | Nutrients | 2022 | 36296970 | PubTator, text mining | PubMed |
| Chemical and Synthetic Biology Approaches for Cancer Vaccine Development. | Molecules | 2022 | 36296526 | PubTator, text mining | PubMed |
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring. | Cancers (Basel) | 2022 | 36291936 | PubTator, text mining | PubMed |
| Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors. | Cancers (Basel) | 2022 | 36291891 | PubTator, text mining | PubMed |
| Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells. | Cancers (Basel) | 2022 | 36291817 | PubTator, text mining | PubMed |
| Advances in Promoting the Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36291802 | PubTator, text mining | PubMed |
| Treatment of Refractory Metastatic Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 36291789 | PubTator, text mining | PubMed |
| A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas. | Brain Sci | 2022 | 36291283 | PubTator, text mining | PubMed |
| The Role of Immunotherapy in Pancreatic Cancer. | Curr Oncol | 2022 | 36290818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=56